VANESA SAMOS: Open Payments
NPI 1114595139 · VALLEY FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,967 in 44 payments from 12 companies in 2025. Trend: 2023 $545 · 2024 $745 · 2025 $1,967
Food & beverage: $1,967
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $384 |
| Janssen Pharmaceuticals, Inc | 8 | $285 |
| Axsome Therapeutics, Inc. | 3 | $276 |
| Otsuka America Pharmaceutical, Inc. | 5 | $222 |
| Alkermes, Inc. | 8 | $192 |
| E.R. Squibb & Sons, L.L.C. | 2 | $165 |
| Novo Nordisk Inc | 2 | $135 |
| Neurocrine BioSciences, Inc. | 2 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $90 |
| ABBVIE INC. | 1 | $65 |
Products named: CAPLYTA, Auvelity, REXULTI, ARISTADA, COBENFY, SPRAVATO, Wegovy, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
